Chapter 37. Schizophrenia Flashcards

1
Q
  1. Which of the following statements is not true?
    A. If the patient has lack of response to two adequate antipsychotic trials, a trial of clozapine should be considered.
    B. All antipsychotics, other than clozapine, have similar efficacy.
    C. It is appropriate to choose an antipsychotic based on which side effects will be most tolerable to the patient.
    D. All antipsychotics have equal risk of weight gain and metabolic disturbances.
    E. The results of the CATIE trial showed some FGAs may be as well tolerated as SGAs.
A

D. All antipsychotics have equal risk of weight gain and metabolic disturbances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Which of the following statements regarding the diagnosis of schizophrenia is true?
    A. The presence of psychosis is diagnostic for schizophrenia.
    B. The presence of disorganization is necessary for diagnosis.
    C. Symptoms must be present for at least 1 week.
    D. Symptoms must be documented by MRI changes.
    E. Social and/or occupational dysfunction must be present.
A

E. Social and/or occupational dysfunction must be present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Which of the following side effects of antipsychotic medications would have a delayed occurrence of onset that is usually months to years after initiation of the medication?
    A. Sedation B. Dry mouth
    C. Tardive dyskinesia
    D. Weight gain
    E. All of the above
A

C. Tardive dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Which of the following schizophrenia symptoms is most likely to respond to antipsychotic treatment?
    A. Hallucinations
    B. Cognition
    C. Impaired judgment
    D. Disorganization
    E. Negative symptoms
A

A. Hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Which of the following situations would be the most appropriate for the use of clozapine?
    A. A 19-year-old patient first presenting with psychotic symptoms
    B. A 65-year-old patient with schizophrenia and multiple myeloma
    C. A 43-year-old patient rehospitalized after nonadherence to olanzapine and risperidone.
    D. A 35-year-old patient rehospitalized after failing treatment with haloperidol
    E. A 33-year-old patient with a lack of response to separate trials of risperidone and aripiprazole
A

E. A 33-year-old patient with a lack of response to separate trials of risperidone and aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Which two antipsychotics are generally associated with the most weight gain in people with schizophrenia?
    A. Risperidone and quetiapine
    B. Aripiprazole and ziprasidone
    C. Clozapine and olanzapine
    D. Olanzapine and aripiprazole
    E. Risperidone and ziprasidone
A

C. Clozapine and olanzapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Adolescents treated with antipsychotics compared with adults:
    A. May be more at risk for EPS
    B. Experience little to no weight gain
    C. Should be started with higher doses
    D. Should be titrated at a faster rate
    E. All of the above
A

A. May be more at risk for EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Which of the following antipsychotic medications does not come in a long-acting injectable formulation?
    A. Clozapine
    B. Risperidone
    C. Olanzapine
    D. Aripirazole
    E. Haloperidol
A

A. Clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Which of the following statements regarding the treatment of schizophrenia is true?
    A. Antipsychotic treatment should continue for up to 4 weeks after remission of symptoms.
    B. Neuroleptic malignant syndrome only occurs with FGA treatment.
    C. Cognitive function is greatly improved by antipsychotic treatments.
    D. Most antipsychotics require dose titration upon initiation for maximum efficacy.
    E. Treatment for schizophrenia usually results in a return to baseline functioning.
A

D. Most antipsychotics require dose titration upon initiation for maximum efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. When treating schizophrenia in the elderly, which is true?
    A. New onset psychosis late in life is most likely late-life schizophrenia.
    B. The same side-effect risk is observed in the elderly compared to younger adults.
    C. Some antipsychotic medications can worsen cognitive ability.
    D. Orthostatic blood pressure changes are not a concern, as most patients are bedridden.
    E. No dosage adjustments are needed when prescribing for the elderly.
A

C. Some antipsychotic medications can worsen cognitive ability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. In patients taking antipsychotics, routine monitoring for metabolic side effects should be performed, including which of the following laboratory and clinical measures?
    A. Lipid panel
    B. Fasting glucose
    C. Body weight
    D. Waist circumference
    E. All of the above
A

E. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Which of the following is not a side effect related to dopamine antagonism?
    A. Prolactin elevation
    B. Tremor
    C. Dizziness
    D. Dystonia
    E. Akathisia
A

C. Dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. In general, an advantage of second-generation antipsychotics (SGAs) over first-generation antipsychotics (FGAs) is their
    A. No risk of tardive dyskinesia
    B. Lower incidence of EPS
    C. Lower cost
    D. Fewer interactions with other medications
    E. Indications for use in the elderly
A

B. Lower incidence of EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. All of the following are true of clozapine except:
    A. Is indicated after the patient has not responded to two adequate antipsychotic trials.
    B. Has no more risk of weight gain than other antipsychotic medications.
    C. Requires blood monitoring for as long as the patient takes the drug.
    D. Is the only antipsychotic with differential efficacy for positive symptoms.
    E. Can cause hypersalivation.
A

B. Has no more risk of weight gain than other antipsychotic medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. When considering the differential diagnosis of a patient presenting with new onset psychotic symptoms, which of the following would make a diagnosis of schizophrenia unlikely?
    A. A young man with psychosis while being treated with a course of steroids.
    B. An elderly person with psychosis in nursing home
    C. A person with severe depression who believes God is punishing him.
    D. A person with a long history of alcohol dependence presents with hallucinations
    E. All of the above
A

E. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A 36-yo patient is diagnosed with schizophrenia being readmitted to your outpatient psychiatrist unirt. She has failed trials with olanzapine, haloperidol, and aripiprazole and is deemed treatment resistant. During her admission she reports worsening depressive symptoms as well and admits to sucidal ideations with a plan. Which of the following treatment options would be most appropriate for AD at this time?

A. Ziprasidone

B. Chlorpromazine

C. Haloperidol + quetiapine

D. Clozapine

A

D. Clozapine

17
Q

Which of the following best describes the recommendation of dosing when using divalproex and lamotrigine concurrently?

A. Divalproex dose needs to be doubled when taken with lamotrigine

B. Lamotrigine dose needs to be doubled when taken with divalproex

C. Divalproex dose needs to be halved when taken with lamotrigine

D. Lamotrigine dose needs to be halved when taken with divalproex

A

D. Lamotrigine dose needs to be halved when taken with divalproex

18
Q

You run an extensive lab work-up. All lab work is normal except for the following: Plts: 60,000, LFTs: 3x upper limit of normal. Which of the following treatment options would be most appropriate for this patient?

A. Carbamazeprine

B. Lithium

C. Divalproex

D. Lamotrigine

A

B. Lithium

19
Q

Based on the PMH, current complaints, and currenty medications, which of the following would be the most appropriate treatment option for this patient?

A. Vilazodone

B. Duloxetine

C. Paroxetine

D. Bupropion

A

B. Duloxetine

20
Q

AD is a 42-yo male admitted with a treatment resistent major depressive disorder, substance abuse (in remission), and chronic back pain due to injuries from a car accident. He has failed trials of fluoxertine, bupropion, citalopramm+ bispirone. He has significant trouble sleeping (averaging 2-3 hours pof sleep a night), poor appetite (BMI down to 18), and he has been having suicidal ideations with a plan to overdose on his medications. Urine drug screen is negative. Which of the following woukld be the most appropriate treatment option for this patient?

A. Sertralione + lorazepam

B. Sertraline + amitripyline

C. Duloxetine + imipramine

D. Duloxetine + mirtazapine

A

D. Duloxetine + mirtazapine

21
Q

Which of the following is false regarding tricyclic overdose?

A. Gastric aspiration is helpful

B. Antiarrhythmia drugs should be used routinely

C. Cardiac monitoring is important

D. Desipramine is the most lethal TCA antidepressant

A

B. Antiarrhythmia drugs should be used routinely

22
Q

The antidepressant action of MAOI is mediated through all of the followiung mechanisms EXCEPT:

A. Inhibition of MAO-A

B. Down-regulation of 5-HT2 receptors

C. Doen regulation of alpha-2 receptors

D. Inhibition of MAO-B

A

D. Inhibition of MAO-B

23
Q

Which of the following pharmacologic differences is importan t in choosing among different SSRIs?

A. Affinity for sigma opioid receptors

Potency in inhibiting 5-HT reuptake

C. Selectivity in inhibiting 5-HT reuptake

D. Inhibition of hepatic cyctochrome P-450 isoenzymes

A

D. Inhibition of hepatic cyctochrome P-450 isoenzymes

24
Q

At which of the following receptors does trazadone act?

A. Histamine (H1) receptors

B. Muscarinic receptors

C. Alpha-adrenergiuc receptors

D. Norepinephrine receptors

A

C. Alpha-adrenergiuc receptors

25
Q

What percentage of D2 receptors must an antipsychotic drug occupy to cause EPS?

A. More than 50%

B. More than 60%

C. More than 70%

D. More than 80%

A

D. More than 80%

26
Q

Which of the following factors predicts a good response to carbamazepine in bipolar disorder

A. History of a good response to lithium

B. Strong family history of bipolar disorder

C. Rapid-cycling mania

D. Unstable episode frequency

A

C. Rapid-cycling mania

27
Q

Which of the following is a good prognostic indicator for response to lithium in bipolar disorder

A. Rapid-cycling mania

B. Episode pattern of depression, mania, euthymia

C. Episode pattern of mania, depression, euthymia

D. Mixed states

A

C. Episode pattern of mania, depression, euthymia

28
Q

Which of the following is considered a feature of metabolic syndrome?

A. Abdominal obesity

B. Elevated triglycerides

C. Low HDL levels

D. BP higher than 135/85

E. All of the above

A

E. All of the above

29
Q

In pharmacodynamic termsd, how is the therapeutic index defined?

A. The dose at which 50% of the patients experiencer a specific toxic effect

B. The dose at which 50% of the patients have a specific therapeutic effect

C. The ratio of the medican toxic dose to the median effective dose

D. None of the above

A

B. The dose at which 50% of the patients have a specific therapeutic effect